IFNA2 and COVID-19: Importantly, serum levels of IFNα in the patient carrying the p.(Pro554Ser/WT) variant during the acute phase of COVID-19 were considerably lower than those found in the cohort of patients hospitalized with unexplained severe COVID-19.